Learn more

ANO NITS BIOTEKHNOLOGII ANTIBIOTIKOV I DRUGIKH BIOLOG AKTIVNYKH VESHCHESTV BIOAN

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    231,691
About

ANO NITS BIOTEKHNOLOGII ANTIBIOTIKOV I DRUGIKH BIOLOG AKTIVNYKH VESHCHESTV BIOAN has a total of 14 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Russian Federation. Its main competitors in its focus markets biotechnology are PILLAR BIOSCIENCES INC, VIENNALAB LABORDIAGNOSTIKA GMB and FUJIAN MEDICAL UNIVERSITY UNION HOSPITAL.

Patent filings in countries

World map showing ANO NITS BIOTEKHNOLOGII ANTIBIOTIKOV I DRUGIKH BIOLOG AKTIVNYKH VESHCHESTV BIOANs patent filings in countries
# Country Total Patents
#1 Russian Federation 14

Patent filings per year

Chart showing ANO NITS BIOTEKHNOLOGII ANTIBIOTIKOV I DRUGIKH BIOLOG AKTIVNYKH VESHCHESTV BIOANs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Biotechnology

Focus technologies

# Technology
#1 Measuring microorganism processes

Top inventors

# Name Total Patents
#1 Danilenko Valerij Nikolaevich 14
#2 Bekker Ol Ga Borisovna 9
#3 Shtil Aleksandr Al Bertovich 4
#4 Preobrazhenskaja Marija Nikolaevna 3
#5 Charushin Valerij Nikolaevich 3
#6 Luzina Ol Ga Anatol Evna 3
#7 Tolshchina Svetlana Gennad Evna 3
#8 Maslov Dmitrij Antonovich 3
#9 Rusinov Gennadij Leonidovich 3
#10 Ishmetova Rashida Irshotovna 3

Latest patents

Publication Filing date Title
RU2566998C1 TEST SYSTEM OF Mycobacterium smegmatis aphVIII + FOR SCREENING OF INHIBITORS OF SERINE-THREONINE PROTEIN KINASES OF EUKARYOTIC TYPE
RU2570622C2 Lactobacillus rhamnosus strain, POSSESSING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY AGAINST PATHOGENIC AND OPPORTUNISTIC VAGINAL MICROFLORA
RU2570907C2 3-acylaminopyridin derivatives, applicable as serine-threonine proteinkinase gsk3b inhibitors, as medications for type ii diabetes treatment
RU2545458C2 ANTITUBERCULOUS THERAPEUTIC AGENT: COMPOSITION OF IMIDAZO[1,2-b]TETRAZINE AND PYRAZINAMIDE
RU2533707C1 Furilidene furanone derivatives of usnic acid as new antituberculosis agents
RU2527258C1 6-SUBSTITUTED 3-AZOLYLIMIDAZO[1,2-b][1,2,4,5]TETRAZINES SHOWING ANTICANCER ACTIVITY
RU2523284C2 Method for modification of macrolide antibiotic oligomycin a by reaction of [3+2]-dipolar cycloconnection of azide and alkines 33-deoxy-33-(triazol-1-yl)-oligomycins a and their biological activity
RU2483722C1 Aminothiazole derivatives of usnic acid as novel anti-tuberculosis agents
RU2477127C1 Preparing quaternised usnic acid derivatives and their biological properties
RU2508406C2 METHOD OF SPECIES IDENTIFICATION OF L.casei/paracasei, L.fermentum, L.plantarum AND L.rhamnosus
RU2526576C2 Method for identifying lactic acid bacilli
RU2462466C1 Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases
RU2454420C1 Cytotoxic semi-synthetic macrolide antibiotic oligomycin a derivatives and synthesis method thereof
RU2466132C1 PIM1-KINASE INHIBITOR 6-[(4-METHYL-I-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H, 10H)-DIONE, METHOD FOR PREPARING AND USING IT